Akèy › Enfeksyon Viral › Distrik Columbia › Washington
Etid klinik pou Enfeksyon Viral nan Washington, DC
12 etid pou Enfeksyon Viral ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Ap rekriteFaz 3
- Research Site, Washington D.C.
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Ap rekriteFaz 1Volontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Ap rekriteFaz 3
- Georgetown University Medical Center, Washington D.C.
- Jadestone Clinical Research, Silver Spring · 7 mi lwen
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Ap rekriteFaz 3
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
- Jadestone Clinical Research, Silver Spring · 7 mi lwen
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Ap rekriteFaz 1Volontè an sante akeyi
- George Washington University, Washington D.C.
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Ap rekriteFaz 1Volontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Viral Infections in Healthy and Immunocompromised Hosts
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Genetic Studies of Chronic Active Epstein-Barr Disease
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Ap rekriteFaz 1
- Children's National Hospital, Washington D.C.
- National Institutes of Health (NIH), Bethesda · 7 mi lwen
Etid Enfeksyon Viral nan lòt vil
- Boston, MA6 etid
- Houston, TX6 etid
- Hialeah, FL5 etid
- Baltimore, MD5 etid
- Atlanta, GA4 etid
- Cincinnati, OH4 etid
- Dallas, TX4 etid
- Columbus, OH4 etid
- Los Angeles, CA3 etid
- Worcester, MA3 etid
- Tampa, FL3 etid
- Miami, FL3 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.